Previous Section
Drug Therapy
1. Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy.
- Author
- Chattaway JM; Klepser TB;
- Institution
- Department of Clinical Pharmacy, College of Pharmacy, Ferris State University, Big Rapids, MI, USA.
- Journal
- Ann Pharmacother. 2007 Jun;41(6):1018-22. Epub 2007 May 15.
- Abstract URL
- Click here to view abstract
2. Spontaneous hypothyroidism in the follow up of Graves hyperthyroid patients treated with antithyroid drugs.
- Author
- De Moraes AV; Pedro AB; Romaldini JH;
- Institution
- Service of Endocrinology, Hospital Servidor Publico Estadual, Iamspe, Sao Paulo, Brazil.
- Journal
- South Med J. 2006 Oct;99(10):1068-72.
- Abstract URL
- Click here to view abstract
3. Effective methimazole dose for childhood Graves' disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery.
- Author
- Slyper AH; Wyatt D; Boudreau C;
- Institution
- Department of Pediatrics, Loyola University Medical Center, Maywood, IL 60153, USA. aslyper@lumc.edu
- Journal
- J Pediatr Endocrinol Metab. 2005 Jun;18(6):597-602.
- Abstract URL
- Click here to view abstract
4. The Relation of Initial Methimazole Dose to the Incidence of Methimazole-induced Agranulocytosis in Patients with Graves' Disease.
- Author
- Tsuboi K; Ueshiba H; Shimojo M; Ishikawa M; Watanabe N; Nagasawa K; Yuasa R; Yoshino G;
- Institution
- of Diabetes, Metabolism and Endocrinology, Department of Medicine, Toho University School of Medicine.
- Journal
- Endocr J. 2007 Mar;54(1):39-43. Epub 2006 Oct 20.
- Abstract URL
- Click here to view abstract
5. Comparison of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Caused by Graves' disease.
- Author
- Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N;
- Institution
- Department of Internal Medicine II, Hamamatsu University School of Medicine, Handayama 1-20-1, Hamamatsu, Shizuoka, Ito Hospital, Tokyo, Kuma Hospital, Kobe, Sumire Hospital, Osaka, Japan.
- Journal
- J Clin Endocrinol Metab. 2007 Mar 27;.
- Abstract URL
- Click here to view abstract
6. Infliximab: a novel treatment for sight-threatening thyroid associated ophthalmopathy.
- Author
- Durrani OM; Reuser TQ; Murray PI;
- Institution
- Academic Unit of Ophthalmology, the University of Birmingham, UK.
- Journal
- Orbit. 2005 Jun;24(2):117-9.
- Abstract URL
- Click here to view abstract
Next: Surgical Therapy
